Optimising cellular pathology with cutting-edge artificial intelligence

Histofy is devoted to the development of world-leading AI algorithms for advanced tissue image analytics that can be seamlessly integrated into existing workflows. Our technology enables pathologists to increase the accuracy and efficiency of reporting, ultimately leading to better patient care.

Histofy Values

Adaptability

We are relentless in the pursuit of better patient care, embracing change and swiftly adjusting to new challenges, ensuring our team seizes new opportunities and thrives in a dynamic environment.

Transparency

We act with honesty, integrity and accountability, building trust within our team and with our stakeholders.

Patient Focus

We prioritise patients, making their wellbeing and needs the primary focus of our efforts, guiding our decisions and innovation.

Empowerment

We foster creativity and personal growth, encouraging leadership and providing the tools and environment for our valued team members to achieve success.

Togetherness

We value partnerships and opportunities for collaboration, respecting and supporting one another to achieve our shared goals.

The Team

Our founding team have accumulated over 50 years of experience in the field of digital and computational pathology and have now come together to help revolutionise the face of pathology.

Nasir Rajpoot, PhD

Co-Founder, CEO & CSO

With over twenty years’ experience as a global leader in computational pathology, Nasir is responsible for providing leadership to our team and formulating our scientific and commercial strategy.

David Snead, FRCPath

Co-Founder, CMO

A renowned expert in cellular pathology, David has devoted the past thirty years to honing his craft. David oversees the development of Histofy’s products and leads on their implementation into practice.

Simon Graham, PhD

Co-Founder, CTO

With a background in mathematics and computer science, Simon has dedicated the past eight years to developing AI for pathology. Simon leads the transformation of AI research into tangible products.

Chien-Hui Liao, PhD

CFO

Chien has over a decade of experience in the financial sector, having taught in a number of universities and completing an MBA in financial management. Chien leads on our financial strategy and operations.

Adnan Khan, PhD

Principal AI Architect

With over a decade of experience in deploying AI systems, Adnan combines his expertise in product development and computational pathology to create impactful AI solutions for clinical applications.

Navid Alemi, PhD

Senior AI Scientist

Navid has seven years’ experience working in academia and industry, developing AI models for digital pathology. Navid is responsible for translating leading research into cutting-edge clinical tools.

Dang Vu, PhD

AI Scientist

Dang has amassed seven years’ experience as a researcher in computational pathology and machine learning. Dang plays an integral role in the research and productisation of our AI algorithms.

John Pocock, PhD

AI Engineer

John has gained over six years’ experience in machine learning and computational pathology in both research and industry settings. John contributes to developing clinical tools for healthcare professionals.

Yuchang Li

Infrastructure Engineer

Yuchang has over five years’ experience as a system administrator. Yuchang is responsible for software deployment, server maintenance and best practices within the machine learning life cycle.

Elysa Cooper

Administrator

Elysa has gained over ten years’ experience in the charity sector, working in operations, event management and administration. Elysa assists with operations, logistics and HR processes.

Scientific Advisory Board

Prof Sabine Tejpar

Oncology

Head of Digestive Oncology

KU Leuven

Prof Mark Arends

Pathology

Head of Pathology

University of Edinburgh

Prof Ali Khurram